Online Program Home
  My Program

Keyword Search

Legend:
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: Drug combination returned 5 record(s)
Monday, 07/31/2017
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades
Sungjin Kim, Cedars-Sinai Medical Center; Marcio Diniz, Cedars Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center


Drug Combination Dose Allocation Using Minimal Sets and Coherence in Partially Ordered Sets in Phase I Cancer Trials
Galen Cook-Wiens, Cedars Sinai Medical Center; Matthieu Clertant, Cedars-Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center


Design of Drug Combination Early Phase Cancer Trials Using Time to Toxicity Data
Marcio Diniz, Cedars Sinai Medical Center; José Jimenez, Politecnico di Torino; Andre Rogatko, Cedars Sinai Medical Center; Mourad Tiguiouart, Cedars Sinai Medical Center


Thursday, 08/03/2017
Dose Selection in Phase 2 Studies for a Drug Combination Using a Response Surface Modeling Technique
Hongtao Zhang, AbbVie Inc.; Jingjing Gao, AbbVie Inc.; Qiming Liao, AbbVie Inc.; Alan Hartford, AbbVie; Jyotirmoy Dey, AbbVie Inc.
8:35 AM

Design of Phase I/II Drug Combination Cancer Trials Using CRM and Adaptive Randomization
Mourad Tighiouart, Cedars-Sinai Medical Center; Matthieu Clertant, Cedars-Sinai Medical Center
9:20 AM

 
 
Copyright © American Statistical Association